DEVELOPMENT OF TDPI INHIBITORS BASED ON DERIVATIVES OF CHROMENE AS POTENTIAL ANTI-CANCER DRUGS
A. A Chepanova , N. S Li-Zhulanov , T. A Kurgina , A. L Zakharenko , O. D Zakharova , K. P Volcho , N. F Salakhutdinov , O. I Lavrik
Genes & Cells ›› 2020, Vol. 15 ›› Issue (3S) : 68 -69.
DEVELOPMENT OF TDPI INHIBITORS BASED ON DERIVATIVES OF CHROMENE AS POTENTIAL ANTI-CANCER DRUGS
| [1] |
Interthal H et al., The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci U S A. 2001;98(21):12009-14. |
| [2] |
Kamaletdinova T et al., The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers. Cells. 2019; 8(12),1625; |
| [3] |
Li-Zhulanov et al., A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold. Molecules, 2018, 23(10), 2468; |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
